Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx

Dataset

Description

Supplementary Figure 1. Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system This table contains the Anatomical Therapeutic Chemical (ATC) codes for all drugs included in this analysis.
Date made available22 Jun 2021
PublisherFuture Science Group

Cite this